Results 121 to 130 of about 2,705,124 (338)

Direct Neutrino Mass Experiments

open access: yes, 2016
With a mass at least six orders of magnitudes smaller than the mass of an electron -- but non-zero -- neutrinos are a clear misfit in the Standard Model of Particle Physics.
Mertens, Susanne
core   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

Automated approaches for band gap mapping in STEM-EELS

open access: yes, 2017
Band gap variations in thin film structures, across grain boundaries, and in embedded nanoparticles are of increasing interest in the materials science community.
Granerød, Cecilie S.   +2 more
core   +1 more source

Determination of bacterial endotoxins in parenteral solutions produced on a small scale in a clinical hospital [PDF]

open access: yesMakedonsko Farmacevtski Bilten
Two different limulus amoebocyte lysate assays of bacterial endotoxins in parenteral solutions produced on a small scale in a clinical hospital are evaluated.
Renata Bozhinovska Popovska   +4 more
doaj   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Mass Measurement of the Decaying Bino at the LHC

open access: yes, 2008
In some class of supersymmetric (SUSY) models, the neutral Wino becomes the lightest superparticle and the Bino decays into the Wino and standard-model particles.
Aad   +21 more
core   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

The role of immunohistochemical analysis in determining the molecular subtypes of bladder cancer

open access: yesУспехи молекулярной онкологии
Introduction. The results of genomic profiling of muscle-invasive bladder cancer (BC) based on messenger RNA (mRNA) extraction showed significant molecular variety of the tumors underlying the wide spectrum of clinical manifestations and responses to ...
M. V. Berkut   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy